logo
[breadcrumb_custom]

Tag: YCBD Shares

Industry

cbdMD Inc (YCBD) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. cbdMD Inc’s current trading price is -89.10% away from its 52-week high, while its distance from the 52-week low is 83.93%. The stock’s price range for this time frame has been between $0.56 and $9.45. The trading volume of the company’s shares in the Healthcare reached around 1.65 million for the day, which was evidently higher than the average daily volume of 0.92 million over the last three months. The market performance of cbdMD Inc has been somewhat unstable.

SLGG
Stock

YCBD’s Stock Journey: What Investors Need to Know About cbdMD Inc’s Performance

cbdMD Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $9.68 on 03/27/23, and the lowest price during that time was $0.56, recorded on 10/31/23. 52-week price history of YCBD Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. cbdMD Inc’s current trading price is -90.59% away from its 52-week high, while its distance from the 52-week low is 62.50%. The stock’s price range for this period has remained between $0.56 and $9.68. The Healthcare

Finance

cbdMD Inc (YCBD) Stock: A Year of Stock Market Dynamics

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. cbdMD Inc’s current trading price is -90.74% away from its 52-week high, while its distance from the 52-week low is 62.50%. The stock’s price range for this time frame has been between $0.56 and $9.83. The trading volume of the company’s shares in the Healthcare reached around 8.73 million for the day, which was evidently higher than the average daily volume of 0.78 million over the last three months. The stock market performance of cbdMD Inc has been fairly